trocar sleeve seal/port reducer
device technologies australia pty ltd - 45597 - trocar sleeve seal/port reducer - to seal a trocar sleeve assembly to inhibit the leakage of the insufflation media whilst providing an alternate channel guide allowing the insertion and exchange of other endoscopic instruments of different diameter through the sleeve during laparoscopic procedures. it is a single use device.the seal has the potential to permit the addition of insufflation media through a port.
tegretol 100 mg/5ml oral suspension
b & s healthcare - carbamazepine - oral suspension - 100 mg/5ml - antiepileptics
eraquell 18.7 mg/g oral paste
virbac de portugal laboratorios - ivermectin - oral paste - 18.7 mg/g - endectoparasiticides - equine - food
virbamec injectable solution 10mg/ml
virbac de portugal laboratorios - ivermectin - solution for injection - 10 mg/ml - endectoparasiticides - bovine
virbamec injectable solution for cattle, swine and sheep 10 mg/ml
virbac de portugal laboratorios - ivermectin - solution for injection - 10 mg/ml - endectoparasiticides - bovine ovine porcine
virbamec pour on solution for cattle 5 mg/ml
virbac de portugal laboratorios - ivermectin - pour-on solution - 5 mg/ml - endectoparasiticides - bovine
virbamec super solution for injection
virbac de portugal laboratorios - ivermectin clorsulon - solution for injection - mg/ml - endectoparasiticides - bovine
aclasta
sandoz pharmaceuticals d.d. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy in post-menopausal women and in men at increased risk of fracture. treatment of paget's disease of the bone.,
aripiprazole sandoz
sandoz gmbh - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole sandoz is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole sandoz is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment. aripiprazole sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.,
atriance
sandoz pharmaceuticals d.d. - nelarabine - precursor t-cell lymphoblastic leukemia-lymphoma - antineoplastic agents - nelarabine is indicated for the treatment of patients with t-cell acute lymphoblastic leukaemia (t-all) and t-cell lymphoblastic lymphoma (t-lbl) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.,